Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Morphometric alteration induced by cyclophosphamide in rat kidney and protective efficacy of coenzyme Q10: A stereological study

Ahmad Yahyazadeh.




Abstract

Cyclophosphamide (CD), as a chemotherapeutic drug, is used for the elimination of cancer cells, but its toxicity has led to health problems. We aimed to investigate the efficacy of coenzyme Q10 (C10) on kidney alterations caused by CD treatment in Wistar albino rats. Thirty-five adult male rats were assigned into five groups: control (CO), olive oil (OO), CD, C10, and CD+C10. All kidney tissues were analysed using the stereological and histopathological techniques. Stereological results revealed that the mean volumes of kidney, cortex, medulla, and glomerulus were significantly increased in the CD group than the CO group (p < 0.05). We also observed a significant decrease in the mean volume of proximal tubules in the CD group than the CO group (p < 0.05). In the CD+C10 group, the mean volumes of kidney, cortex, medulla, and glomerulus were significantly less when compared to the CD group (p < 0.05). In addition, there was a significant increase in the mean volume of proximal tubules in the CD+C10 group than the CD group (p < 0.05). Histopathological examination also revealed valuable results. Our findings showed that treatment with CD caused destructive change in the rat kidney tissues. Moreover, C10 administration significantly attenuated the toxic effect of CD on the kidneys.

Key words: Coenzyme Q10, cyclophosphamide, kidney, rat






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.